# Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides

> **NCT05282485** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Columbia University** · enrollment: 140 (actual)

## Conditions studied

- HIV
- Infant Morbidity
- Breast Feeding

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT05282485
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-02
- **Primary completion:** 2026-09-15
- **Final completion:** 2026-09-15
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282485, "Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05282485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*